Options for the treatment of psoriasis: a multifactorial approach

References 

1. van de Kerkhof PCM. Psoriasis. In:  Bologna JL,  Jorizzo JL,  Rapini RP, et al. editor. Dermatology. London: Mosby; 2003;p. 125–149
2. Gupta MA, Gupta AK, Kirby S. A psychocutaneous profile of psoriasis patients who are stress reactors. Gen Hosp Psych. 1989;11:166–173
3. Skov L, Baadgaard O. Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol. 2000;25:56–61
4. Tsankov N, Angelova I, Kazandjieva R. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol. 2000;1:159–165
   • MEDLINE
   • CrossRef
5. Higgins E. Alcohol, smoking and psoriasis. Clin Exp Dermatol. 2000;25:107–110
   • MEDLINE
   • CrossRef
6. Christophers E. Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314–320
   • MEDLINE
   • CrossRef
7. Kirby B, Fortune DG, Bhusham M, Chalmers RJ, Griffiths CEM. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol. 2000;142:728–732
   • MEDLINE
   • CrossRef
8. Frederickson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157:238–244
   • MEDLINE
9. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152:861–867
   • MEDLINE
   • CrossRef
10. van de Kerkhof PCM, Kragballe K The CPWG. Psoriasis: severity assessment in clinical practice. Eur J Dermatol. 2006;16:1–5
11. Rapp SR, Feldmann SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–407
    • Abstract
    • Full Text
    • Full-Text PDF (96 KB)
    • CrossRef
12. De Korte J, Mombers FMC, Sprangers MAG, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol. 2002;138:1221–1227
    • MEDLINE
    • CrossRef